Clinical Validation of Programmable Drain Fluid Regulator to Reduce Morbidity, Care Requirements, and Improve Outcomes
Pleural Effusion, Ascites
About this trial
This is an interventional treatment trial for Pleural Effusion focused on measuring Medical device, Pleural effusion, Ascites, Drainage, Novel
Eligibility Criteria
Inclusion Criteria: Pleural effusion or ascites as the primary indication for chest or abdominal drain insertion Expected ascites drainage volume more than 1 Litre or at least moderate sized pleural effusion (occupying more than one-third hemi-thorax) uncomplicated chest or abdominal drain insertion Adults aged 21 years, able to provide (or surrogate able to provide) consent. Exclusion Criteria: Vulnerable persons, including but not limited to, pregnant women and prisoners Hemodynamic instability, defined by heart rate more than 120 beats per minutes and blood pressure less than systolic 90mmHg Haemothorax or Haemoperitoneum pneumothorax or pneumoperitoneum chest or abdominal drain insertion => 48 hours with more than estimated 50% of total body cavity fluid drained
Sites / Locations
- Changi General HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Pleural Arm
Ascites arm
Patient's maximum volume is 1 litre per hour, not to exceed total 4 litres over 4 hours
Patient's maximum volume is 3 litre per hour, not to exceed total 15 litres over 5 hours